Literature DB >> 7418593

Chronic active hepatitis. Who meets treatment criteria?

R L Koretz, K J Lewin, J Higgins, N D Fagen, G L Gitnick.   

Abstract

In order to ascertain the proportion of patients with biopsy-proven chronic active hepatitis who meet currently accepted criteria for immunosuppressive treatment, an analysis of 86 patients seen between 1973 and 1978 carrying this diagnosis was undertaken. Only 66 could be confirmed to have this lesion on blind histologic review. Nine of these 66 were on concomitant immunosuppressive therapy, four had inadequate documentation of chronicity, five consumed more than two ounces of alcohol daily, five had concurrent malignancy, two were prepubertal, and one had oxyphenisatin-induced disease. None of the remaining 40 patients met the biochemical criteria for disease activity. The disease was predominantly seen in asymptomatic middle-aged males and was of viral etiology. A small subgroup of elderly female patients was also identified whose disease was apparently nonviral. In conclusion, the vast majority of chronic active hepatitis seen at a large university center occurs in individuals for whom treatment guidelines have not been established.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7418593     DOI: 10.1007/bf01308329

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  11 in total

1.  Editorial: Asymptomatic chronic hepatitis.

Authors:  P H Plotz
Journal:  Gastroenterology       Date:  1975-06       Impact factor: 22.682

2.  Treatment of chronic active hepatitis. An analysis of three controlled trials.

Authors:  E C Wright; L B Seeff; P D Berk; A Jones; P H Plotz
Journal:  Gastroenterology       Date:  1977-12       Impact factor: 22.682

3.  Sex, ascites and alcoholism in survival of patients with cirrhosis. Effect of prednisone.

Authors: 
Journal:  N Engl J Med       Date:  1974-08-08       Impact factor: 91.245

4.  Controlled trial of prednisone and azathioprine in active chronic hepatitis.

Authors:  I M Murray-Lyon; R B Stern; R Williams
Journal:  Lancet       Date:  1973-04-07       Impact factor: 79.321

5.  A classification of chronic hepatitis.

Authors:  J De Groote; V J Desmet; P Gedigk; G Korb; H Popper; H Poulsen; P J Scheuer; M Schmid; H Thaler; E Uehlinger
Journal:  Lancet       Date:  1968-09-14       Impact factor: 79.321

6.  Controlled prospective trial of corticosteroid therapy in active chronic hepatitis.

Authors:  G C Cook; R Mulligan; S Sherlock
Journal:  Q J Med       Date:  1971-04

7.  Chronic active liver disease. The range of histologic lesions, their response to treatment, and evolution.

Authors:  A H Baggenstoss; R D Soloway; W H Summerskill; L R Elveback; L J Schoenfield
Journal:  Hum Pathol       Date:  1972-06       Impact factor: 3.466

8.  Contrasting features and responses to treatment of severe chronic active liver disease with and without hepatitis BS antigen.

Authors:  S W Schalm; W H Summerskill; G L Gitnick; L R Elveback
Journal:  Gut       Date:  1976-10       Impact factor: 23.059

9.  Immunosuppressive therapy for chronic active hepatitis.

Authors: 
Journal:  Lancet       Date:  1978-09-02       Impact factor: 79.321

10.  "Nonalcoholic" chronic hepatitis in the alcoholic.

Authors:  S J Goldberg; C L Mendenhall; A M Connell; A Chedid
Journal:  Gastroenterology       Date:  1977-04       Impact factor: 22.682

View more
  7 in total

Review 1.  Chronic hepatitis: a review.

Authors:  R A Bradbear
Journal:  J R Soc Med       Date:  1985-05       Impact factor: 5.344

2.  Chronic hepatitis in the 1980s.

Authors:  J Hegarty; R Williams
Journal:  Br Med J (Clin Res Ed)       Date:  1985-03-23

3.  The course of chronic active hepatitis.

Authors:  Y Arthurs; G D Doyle; J F Fielding
Journal:  Ir J Med Sci       Date:  1982-10       Impact factor: 1.568

4.  Chronic active hepatitis (CAH): criteria for treatment.

Authors:  E Ascione; C Linardi
Journal:  Dig Dis Sci       Date:  1982-12       Impact factor: 3.199

Review 5.  Difficult treatment decisions in autoimmune hepatitis.

Authors:  Albert J Czaja
Journal:  World J Gastroenterol       Date:  2010-02-28       Impact factor: 5.742

Review 6.  Autoimmune Hepatitis in the Elderly: Diagnosis and Pharmacologic Management.

Authors:  Syed Rizvi; Samer Gawrieh
Journal:  Drugs Aging       Date:  2018-07       Impact factor: 3.923

Review 7.  Non-classical phenotypes of autoimmune hepatitis and advances in diagnosis and treatment.

Authors:  Albert J Czaja; Yusuf Bayraktar
Journal:  World J Gastroenterol       Date:  2009-05-21       Impact factor: 5.742

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.